176 related articles for article (PubMed ID: 38791355)
1. Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.
Peña-Bautista C; Álvarez-Sánchez L; García-Lluch G; Raga L; Quevedo P; Peretó M; Balaguer A; Baquero M; Cháfer-Pericás C
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791355
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.
Byeon SK; Madugundu AK; Jain AP; Bhat FA; Jung JH; Renuse S; Darrow J; Bakker A; Albert M; Moghekar A; Pandey A
Mol Omics; 2021 Jun; 17(3):454-463. PubMed ID: 34125126
[TBL] [Abstract][Full Text] [Related]
3. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
Lim WLF; Huynh K; Chatterjee P; Martins I; Jayawardana KS; Giles C; Mellett NA; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Drew BG; Masters CL; Meikle PJ; Martins RN;
J Alzheimers Dis; 2020; 76(1):303-315. PubMed ID: 32474467
[TBL] [Abstract][Full Text] [Related]
4. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
5. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.
Adunsky A; Chesnin V; Ravona R; Harats D; Davidson M
Arch Gerontol Geriatr; 2004; 38(1):61-8. PubMed ID: 14599705
[TBL] [Abstract][Full Text] [Related]
7. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.
Patra K; Soosaipillai A; Sando SB; Lauridsen C; Berge G; Møller I; Grøntvedt GR; Bråthen G; Begcevic I; Moussaud S; Minthon L; Hansson O; Diamandis EP; White LR; Nielsen HM
Alzheimers Res Ther; 2018 Jan; 10(1):9. PubMed ID: 29378650
[TBL] [Abstract][Full Text] [Related]
8. Untargeted lipidomics reveals progression of early Alzheimer's disease in APP/PS1 transgenic mice.
Zhang X; Liu W; Zan J; Wu C; Tan W
Sci Rep; 2020 Sep; 10(1):14509. PubMed ID: 32884056
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
Teitsdottir UD; Halldorsson S; Rolfsson O; Lund SH; Jonsdottir MK; Snaedal J; Petersen PH
J Alzheimers Dis; 2021; 81(1):231-244. PubMed ID: 33814423
[TBL] [Abstract][Full Text] [Related]
10. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Andreasson U; Zetterberg H; Blennow K;
JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipidome is dysregulated in Alzheimer's disease and is associated with disease risk genes.
Liu Y; Thalamuthu A; Mather KA; Crawford J; Ulanova M; Wong MWK; Pickford R; Sachdev PS; Braidy N
Transl Psychiatry; 2021 Jun; 11(1):344. PubMed ID: 34092785
[TBL] [Abstract][Full Text] [Related]
12. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
[TBL] [Abstract][Full Text] [Related]
13. Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles.
Llano DA; Issa LK; Devanarayan P; Devanarayan V; Alzheimer's Disease Neuroimaging Initiative Adni
Cells; 2020 Nov; 9(12):. PubMed ID: 33260532
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal change of biomarkers in cognitive decline.
Lo RY; Hubbard AE; Shaw LM; Trojanowski JQ; Petersen RC; Aisen PS; Weiner MW; Jagust WJ;
Arch Neurol; 2011 Oct; 68(10):1257-66. PubMed ID: 21670386
[TBL] [Abstract][Full Text] [Related]
15. The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease.
Dakterzada F; Jové M; Cantero JL; Mota-Martorell N; Pamplona R; Piñoll-Ripoll G
Alzheimers Dement; 2024 May; 20(5):3322-3333. PubMed ID: 38534027
[TBL] [Abstract][Full Text] [Related]
16. Lipidomic Analysis of Plasma Extracellular Vesicles Derived from Alzheimer's Disease Patients.
Krokidis MG; Pucha KA; Mustapic M; Exarchos TP; Vlamos P; Kapogiannis D
Cells; 2024 Apr; 13(8):. PubMed ID: 38667317
[TBL] [Abstract][Full Text] [Related]
17. Plasma tau in Alzheimer disease.
Mattsson N; Zetterberg H; Janelidze S; Insel PS; Andreasson U; Stomrud E; Palmqvist S; Baker D; Tan Hehir CA; Jeromin A; Hanlon D; Song L; Shaw LM; Trojanowski JQ; Weiner MW; Hansson O; Blennow K;
Neurology; 2016 Oct; 87(17):1827-1835. PubMed ID: 27694257
[TBL] [Abstract][Full Text] [Related]
18. The relationship between CSF biomarkers and cerebral metabolism in early-onset Alzheimer's disease.
Jaillard A; Vanhoutte M; Maureille A; Schraen S; Skrobala E; Delbeuck X; Rollin-Sillaire A; Pasquier F; Bombois S; Semah F
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):324-333. PubMed ID: 30155553
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
Honig LS; Kang MS; Lee AJ; Reyes-Dumeyer D; Piriz A; Soriano B; Franco Y; Coronado ZD; Recio P; Mejía DR; Medrano M; Lantigua RA; Teich AF; Dage JL; Mayeux R
JAMA Netw Open; 2023 Apr; 6(4):e238214. PubMed ID: 37079306
[TBL] [Abstract][Full Text] [Related]
20. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
